United Network Revolutionizes Digital Asset Management with the Launch of its NFC Non-Custodial Card Wallet
United Network is proud to announce the official launch of its innovative NFC non-custodial card wallet, transforming a traditional bank card into a secure hardware crypto tool. This innovative solution ensures all transactions are secured directly on the chip, providing unparalleled security and ease of use for digital asset management. All private keys are stored only on the card and are never shared with any external devices or services, ensuring a high level of security.
The United Network card wallet offers a seamless user experience through its intuitive web interface or mobile application. Users can manage their digital crypto assets with the simplicity of NFC authentication via their smartphone and advancement of hardware wallet , making complex cryptocurrency operations as easy as a tap.
The card form factor helps eliminate the complicated usage often associated with traditional hardware wallets, such as the need to connect to a desktop or laptop by cable. The solution was developed according to strict data protection standards. Every device undergoes security testing, so users can be confident their funds are safe, even in case of a card loss.
Key Highlights of the United Network Card Wallet:
United Network aims to make the digital economy accessible to everyone by lowering entry barriers and providing a secure way to manage digital assets.
According to analytics agencies, there are over 400 million cryptocurrency users and more than 1 billion active crypto wallets globally. However, only about 2% of users store their assets on specialized high-security devices. Most continue using online wallets and centralized exchanges, putting their funds at risk.
United Network is dedicated to building a user-friendly non-custodial wallet accessible on every NFC-enabled smartphone. This versatile solution caters to personal use, corporate solutions, and white-label partnerships, aiming to democratize access to secure digital finance.
For more information, visit the official website at https://united.network
The card is now available for worldwide delivery https://get.united.network
Danylo Rumiantsev
[email protected]
+971582944783
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA's list of AI authorizations for 4th Year with 100
Increased R&D investments to integrate AI on devices across disease states designed to boost productivity, efficiency, and diagnostic confidence for healthcare professionals, and drive the company's long-term growth Milestone advances GE HealthCare's goal of attaining more than 200 authorizations by 2028 CHICAGO, July 23, 2025--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the U.S. This milestone reflects GE HealthCare's continued research and development (R&D) investment and focus on developing AI solutions to advance precision care by enhancing medical devices across the care journey. Smart devices, software, and cloud-based solutions, which are central to GE HealthCare's precision care strategy, help enhance outcomes for patients, improve the daily work of care teams, and boost healthcare professional efficiency. These AI-enabled devices help solve customer challenges and are in high demand, which contributes to orders, revenue, and growth for the company. The momentum demonstrates GE HealthCare's progress toward achieving its goal of securing more than 200 authorizations. "Our sustained leadership in AI-enabled medical devices reflects our commitment to research and development, which is powering the creation of next-generation solutions. These solutions are designed to address the toughest challenges our customers are facing including care team shortages and burnout, rising costs, and inefficient workflows," said Dr. Taha Kass-Hout, GE HealthCare's Global Chief Science and Technology Officer. "As we continue to drive the industry forward, we remain committed to doing so in a responsible way, building in our Responsible AI principles at every stage of our product development which include a focus on safety, validity, transparency, explainability, and fairness." The FDA's webpage, Artificial Intelligence-Enabled Medical Devices, provides a list of device authorizations, granted through 510(k) clearances, De Novo requests, or by premarket approval (PMA). GE HealthCare's 100 authorizations to date demonstrate innovation across imaging modalities and care pathways including oncology, cardiology, and neurology, helping to ease the burden of care and improve workflows for healthcare systems. Examples of GE HealthCare's AI solutions that are helping solve customer challenges and driving growth include: AI-based Auto Positioning uses deep learning to automatically detect anatomical landmarks, which are used to determine the patient's orientation inside computed tomography (CT) and positron emission tomography (PET)/CT devices, including Revolution Apex platform and Omni Legend. The solution helps minimize the action required by technologists into a single click operation, enabling faster patient positioning compared to traditional manual positioning operations.1 AIR™ Recon DL is a pioneering deep learning algorithm for image reconstruction that enables radiologists to achieve pin-sharp images quicker. By combining magnetic resonance imaging (MRI) with deep learning, AIR™ Recon DL reduces artifacts, enhances image clarity, and shortens scan times by up to 50%.2 It has been estimated that more than 50 million patients have been scanned since its launch in 2020.3 The LOGIQ™ Series ultrasound portfolio of systems empowers clinicians to scan, diagnose, and treat a wide range of patients and conditions. With AI-powered automation, real-time workflow enhancements, and exceptional image quality, the LOGIQ Series is designed to facilitate faster, more efficient scanning and support diagnostic precision. Intelligent anatomy recognition enables dynamic image optimization as well as repeatable and reproducible automated measurements and results – providing elevated accuracy and greater diagnostic confidence. Precision DL is deep learning-based image processing, available on the Omni Legend PET/CT system, that enhances image quality in PET/CT scans, providing clinicians with a powerful solution to aid in precise diagnoses, treatment planning, and monitoring with the image quality performance benefits typically associated with hardware-based Time-of-Flight (ToF) reconstruction, without compromising sensitivity, including improved contrast-to-noise ratio, contrast recovery4, and quantitative accuracy.5 Venue Family point-of-care ultrasound systems with AI-powered Caption Guidance™ software provides real-time, step-by-step guidance to help even new ultrasound users capture cardiac views and diagnostic-quality images successfully. "We're accelerating the pace of innovation to meet the urgency of today's healthcare challenges. Reaching this milestone is also an important step along our journey of evolving from an imaging company to a healthcare solutions provider, enabling us to deliver holistic and integrated solutions that meet our customers' needs today and will help enable them to stay ahead in a rapidly evolving healthcare environment," said Kass-Hout. GE HealthCare is pushing forward the boundaries of innovation by fostering new ways to use AI, cloud, and software to move the future of healthcare forward in a responsible way in devices, across the care journey, and at the hospital system level. These projects and innovations run the gamut from early R&D to commercially available solutions, often the result of working closely with leading medical institutions, universities, and technology companies to bring in the best thinking from industry, technology, and academia. Regardless of a project's maturity, GE HealthCare combines deep healthcare expertise, a commitment to responsible innovation, and pioneering spirit to help customers address pressing global challenges from aging populations, chronic disease management, remote care, and more. For more information about GE Healthcare's AI-enabled medical device and enterprise software solutions, visit About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™. Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website for more information. 1 "AI-based Auto Positioning," February 2021, 2 AIR™ Recon DL, 3 Calculated using IB data with an estimation of 20 scans per day, 5.5 days per week, from 4 weeks after delivery to April 2025. 4 Precision DL with Omni Legend 32cm data improves Contrast Recovery (CR) by 11% on average and Contrast-to-Noise Ratio (CNR) by average of 23% as compared to non-ToF reconstruction. CR and CNR demonstrated using clinical data with inserted lesions of known size, location, and contrast. Using data from Omni Legend 32 cm, CR and CNR were measured using High Precision DL and QCHD. 5 Precision DL with Omni Legend 32cm improves feature quantitation accuracy by 14% as compared to Discovery MI with ToF reconstruction, at comparable noise level. Quantitation accuracy demonstrated using clinical data with inserted lesions of known size, location, and contrast (ground truth). Feature SUVmean from Omni Legend 32 cm with High Precision DL compared to SUVmean from Discovery MI 25 cm with QCFX. View source version on Contacts GE HealthCare Media Contact Sofia Mata-LeclercHead of Communications, Science and
Forbes
17 hours ago
- Forbes
What The FDA's Guidance On AI-Enabled Devices Gets Right And Wrong
Founder, Blue Goat Cyber | MedTech Cybersecurity Leader | Speaker & Author | 24x Ironman | Securing Innovation & Patient Safety. Integrating AI into medical devices brings the industry a new level of innovation. The benefits can help both providers and patients but also introduce more risk. The Food and Drug Administration (FDA), which has already authorized over 1,000 AI-enabled medical devices, issued draft guidance about the potential threats involved with these devices. Their draft guidance seeks to help device manufacturers create the best governance safeguards for AI. The FDA requested feedback, and it came in abundance. So why is the draft guidance causing such havoc? And what's the next move? The Guidance Focuses Too Much On Complex AI AI's application in any technology is unique. In the medical device industry, it's even more so because every product works differently and has very specific use cases. The biggest complaint I and others in my spaces have on the content is that it speaks to complex devices but not simpler ones. The FDA's guidance, from my perspective, isn't inclusive, possibly not grasping the variety of products on the market. They may also have misconceptions that manufacturers only integrate AI into these complex products. I believe their historical data on approvals of AI-enabled devices likely tells a different story. The reality is that any device, from infusion pumps to glucose monitors and diagnostic tools, can benefit from AI. The devices that fit into the complex category are a niche group. These would include systems with deep learning capabilities. You'll see this mainly in imaging, diagnostics or some applications of predictive analytics. Frameworks Should Align With The AI System Used With unique AI applications for every device, the FDA is not addressing the fact that this impacts cybersecurity risk. Very rigid controls are certainly necessary for many, but not all. What this does is force manufacturers to follow guidance that isn't relevant, creating burdens on these companies. The Advanced Medical Technology Association (AdvaMed) was a key voice in the feedback, stating, "Many of the recommendations in the AI Lifecycle draft guidance are not relevant for less complex AI-machine learning (ML) models." This position makes complete sense to me. Regulatory bodies have never made approvals easy, but this guidance just doesn't align with what experts in the industry know to be true. AI can be a threat, but it's not one type, nor is it all risk even. Commenters also noted that the FDA's existing guidance for device software functions is sufficient for simpler AI models. FDA Doesn't Fully Address TPLC The FDA's approach was to cover the total product life cycle (TPLC). That's essential because elements in each cycle must heed security, and developers would need to use this framework from start to end. From my view, the document omits quite a bit about the product life cycle. There's confusion about what pertains to compliance with internal products. Without clarity, manufacturers are left with more questions and obstacles in submitting their premarket submissions. Another flaw that I see is that the guidance doesn't include post-market monitoring requirements. The document said it's a good practice but not a mandate, nor does it give any specifics on this, like auditing or pen-testing. The FDA's 2023 medical device cybersecurity update does include this. It requires manufacturers to have plans for ongoing monitoring of vulnerabilities and issuing patches to correct them. What Does The Guidance Get Right? While some stakeholders want the FDA to scrap everything and start over, some areas make sense to me. There are many mentions and guidance related to transparency in the process, which should be a tenet. Transparency is present in the 2023 document and requires a software bill of materials (SBOMs). The document also explains the threats of AI and cites the 2023 guidance, aligning with its content around cybersecurity controls and risk management best practices. It goes on to describe how to combat AI cybersecurity risks using the 2023 framework. What's Next? The period for submitting comments has closed. The FDA can integrate these concerns into new language before it moves from draft to published. The range of edits or changes they'll make may be significant or minor. There's no questioning that AI should have governance and guardrails. As much good as it can bring, it also heightens risk. Medical device cyberattacks are already common. The additional layer of AI can make them more susceptible to these threats. The guidance is imperfect. The topic of AI cybersecurity in medical devices is broad and has many nuances. Whatever the final document entails, it won't cover every scenario. What it should do is address as much as possible under the known use cases and risk levels because it can't be a one-size-fits-all approach. Getting this right could usher in an era of more innovation in AI, and that's good news—as long as there are controls and transparency. Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Associated Press
18 hours ago
- Associated Press
Pear Project Services Helps Businesses Save Up to 70% on Used Office Furniture
07/22/2025, Denver, CO // KISS PR Brand Story PressWire // Businesses in Colorado are discovering the value of upgrading their workspaces with high-quality used office furniture from Pear Project Services. Serving Denver, Colorado Springs, Greeley, Boulder, Fort Collins, and the entire Front Range, the company specializes in sourcing and reselling high-quality office furniture from top brands at a fraction of the cost of buying new. With more than 30 years of experience in office design, furnishing, and installation, Pear Project Services helps companies save up to 70% while creating efficient and stylish workplaces. Its extensive inventory of commercial grade office furniture includes trusted brands like Herman Miller, Steelcase, Allsteel, HON, and Knoll, pieces built to last and elevate any professional space. By opting for used office furniture, businesses can completely transform their workspaces into modern and productive environments while supporting sustainability by keeping durable furniture out of landfills. This eco-friendly choice benefits both the bottom line and the planet, proving that affordability and quality can go hand in hand. From startups setting up their first offices to established corporations expanding operations, Pear Project Services offers tailored solutions for every need. More than just a reseller of office furniture in Denver, it provides full-service solutions, including space planning, design consultations, furniture installation, and reconfiguration services. Its commercial relocation services take the stress out of moving or restructuring, helping clients stay focused on their business while it handles the logistics. Pear Project Services stands out for its personalized approach and expertise. Every project begins with a thoughtful consultation to understand the client's goals, aesthetic preferences, and functional needs. Its experienced team helps optimize office layouts for productivity and employee well-being, ensuring each space is both beautiful and practical. Whether furnishing a single office or an entire floor, the company delivers quality, value, and dependable service every step of the way. Pear Project Services's Denver-based showroom and warehouse allow clients to see and feel the furniture before making a decision. Knowledgeable staff are available to provide guidance on choosing the right pieces and configuring the perfect layout. With decades of experience and a hands-on approach, Pear Project Services has earned the trust of many businesses throughout Colorado as a reliable partner for office transformations. By offering premium used office furniture, including commercial-grade office furniture, it helps businesses create professional and polished spaces while staying within budget. Serving Denver and nearby cities, Pear Project Services provides sustainable, high-quality office solutions across the Front Range. For more details about its services, inventory, and showroom hours, visit its website at or stop by their Denver facility to speak with a consultant. About Pear Project Services Pear Project Services helps businesses in Colorado transform their offices into efficient and stylish workplaces with premium used office furniture and planning and installation services. With over 30 years of experience, it is the trusted one-stop shop for office design and furnishings in Denver. ### Media Contact Pear Project Services 11100 E 55th Ave Suite A, Denver, CO 80239 (303) 351-2259 newsroom: Source published by Submit Press Release >> Pear Project Services Helps Businesses Save Up to 70% on Used Office Furniture
